{"transactions":[{"id":823596,"issuer":{"id":7215,"kind":"organization","name":"Genenta Science S.p.A."},"owners":[{"id":54830,"kind":"person","name":"Sharei Armon","position":1,"cik":"0001829463","reported_name":"Sharei Armon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-04-01T20:05:21.000Z","date":"2026-03-30","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest in equal monthly installments over one year beginning March 30, 2026."}],"balance_after":20000,"derivative":{"exercise_price":0.63,"expiration_date":"2035-12-31","underlying":"American Depositary Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001493152-26-014631","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1838716/000149315226014631/ownership.xml","form_type":"4"}},{"id":2213924,"issuer":{"id":112267,"kind":"organization","name":"SQZ Biotechnologies Co","symbol":"SQZ"},"owners":[{"id":54830,"kind":"person","name":"Sharei Armon","position":1,"cik":"0001829463","reported_name":"Sharei Armon","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-07-05T17:00:53.000Z","date":"2022-06-30","kind":"grant","acquired":true,"shares":2436,"price":2.703,"value":6584.508,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reporting person is voluntarily reporting the acquisition on June 30, 2022 of 2,436 shares of the issuer's common stock pursuant to the issuer's employee stock purchase plan."}],"balance_after":287884,"source":{"system":"sec-edgar","filing":"0001209191-22-040781","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604477/000120919122040781/doc4.xml","form_type":"4"}},{"id":2393907,"issuer":{"id":112267,"kind":"organization","name":"SQZ Biotechnologies Co","symbol":"SQZ"},"owners":[{"id":54830,"kind":"person","name":"Sharei Armon","position":1,"cik":"0001829463","reported_name":"Sharei Armon","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option","published_at":"2022-02-15T17:15:34.000Z","date":"2022-02-10","kind":"grant","acquired":true,"shares":395000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable as to 25% of the underlying securities on February 10, 2023 and in 36 substantially equal monthly installments thereafter."}],"balance_after":395000,"derivative":{"exercise_price":6.57,"expiration_date":"2032-02-09","underlying":"Common Stock","underlying_shares":395000},"source":{"system":"sec-edgar","filing":"0001209191-22-009831","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604477/000120919122009831/doc4.xml","form_type":"4"}},{"id":2435659,"issuer":{"id":112267,"kind":"organization","name":"SQZ Biotechnologies Co","symbol":"SQZ"},"owners":[{"id":54830,"kind":"person","name":"Sharei Armon","position":1,"cik":"0001829463","reported_name":"Sharei Armon","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option","published_at":"2022-01-13T17:15:13.000Z","date":"2022-01-12","kind":"exercise","acquired":false,"shares":13000,"price":1.81,"value":23530.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Options were exercised and held for tax planning purposes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was originally granted for 286,514 shares. The option vested and became exercisable as to the original share amount as to 25% of the underlying securities on October 11, 2017 and in 36 equal monthly installments thereafter."}],"balance_after":171937,"derivative":{"exercise_price":1.81,"expiration_date":"2026-10-10","underlying":"Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001209191-22-003218","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1604477/000120919122003218/doc4.xml","form_type":"4"}},{"id":2435658,"issuer":{"id":112267,"kind":"organization","name":"SQZ Biotechnologies Co","symbol":"SQZ"},"owners":[{"id":54830,"kind":"person","name":"Sharei Armon","position":1,"cik":"0001829463","reported_name":"Sharei Armon","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-01-13T17:15:13.000Z","date":"2022-01-12","kind":"exercise","acquired":true,"shares":13000,"price":1.81,"value":23530.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Options were exercised and held for tax planning purposes."}],"balance_after":285448,"source":{"system":"sec-edgar","filing":"0001209191-22-003218","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604477/000120919122003218/doc4.xml","form_type":"4"}},{"id":2447331,"issuer":{"id":112267,"kind":"organization","name":"SQZ Biotechnologies Co","symbol":"SQZ"},"owners":[{"id":54830,"kind":"person","name":"Sharei Armon","position":1,"cik":"0001829463","reported_name":"Sharei Armon","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-01-04T17:15:35.000Z","date":"2021-12-31","kind":"grant","acquired":true,"shares":1686,"price":7.5905,"value":12797.583,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reporting person is voluntarily reporting the acquisition on December 31, 2021 of 1,686 shares of the issuer's common stock pursuant to the issuer's employee stock purchase plan."}],"balance_after":272448,"source":{"system":"sec-edgar","filing":"0001209191-22-000983","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604477/000120919122000983/doc4.xml","form_type":"4"}},{"id":2460525,"issuer":{"id":112267,"kind":"organization","name":"SQZ Biotechnologies Co","symbol":"SQZ"},"owners":[{"id":54830,"kind":"person","name":"Sharei Armon","position":1,"cik":"0001829463","reported_name":"Sharei Armon","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option","published_at":"2021-12-22T17:15:10.000Z","date":"2021-12-22","kind":"exercise","acquired":false,"shares":11049,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Options were exercised and held for tax planning purposes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was originally granted for 286,514 shares. The option vested and became exercisable as to the original share amount as to 25% of the underlying securities on October 11, 2017 and in 36 equal monthly installments thereafter."}],"balance_after":184937,"derivative":{"exercise_price":1.81,"expiration_date":"2026-10-10","underlying":"Common Stock","underlying_shares":11049},"source":{"system":"sec-edgar","filing":"0001209191-21-070962","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1604477/000120919121070962/doc4.xml","form_type":"4"}},{"id":2460524,"issuer":{"id":112267,"kind":"organization","name":"SQZ Biotechnologies Co","symbol":"SQZ"},"owners":[{"id":54830,"kind":"person","name":"Sharei Armon","position":1,"cik":"0001829463","reported_name":"Sharei Armon","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-12-22T17:15:10.000Z","date":"2021-12-22","kind":"exercise","acquired":true,"shares":11049,"price":1.81,"value":19998.69,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Options were exercised and held for tax planning purposes."}],"balance_after":270762,"source":{"system":"sec-edgar","filing":"0001209191-21-070962","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604477/000120919121070962/doc4.xml","form_type":"4"}},{"id":2818736,"issuer":{"id":112267,"kind":"organization","name":"SQZ Biotechnologies Co","symbol":"SQZ"},"owners":[{"id":54830,"kind":"person","name":"Sharei Armon","position":1,"cik":"0001829463","reported_name":"Sharei Armon","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-02T17:32:33.000Z","date":"2021-02-27","kind":"exercise","acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Options were exercised and held for tax planning purposes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was originally granted for 286,514 shares. The option vested and became exercisable as to the original share amount as to 25% of the underlying securities on October 11, 2017 and in 36 equal monthly installments thereafter."}],"balance_after":195986,"derivative":{"exercise_price":1.81,"expiration_date":"2026-10-10","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0000899243-21-009031","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1604477/000089924321009031/doc4.xml","form_type":"4"}},{"id":2818735,"issuer":{"id":112267,"kind":"organization","name":"SQZ Biotechnologies Co","symbol":"SQZ"},"owners":[{"id":54830,"kind":"person","name":"Sharei Armon","position":1,"cik":"0001829463","reported_name":"Sharei Armon","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-03-02T17:32:33.000Z","date":"2021-02-27","kind":"exercise","acquired":true,"shares":8000,"price":1.81,"value":14480.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Options were exercised and held for tax planning purposes."}],"balance_after":259713,"source":{"system":"sec-edgar","filing":"0000899243-21-009031","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604477/000089924321009031/doc4.xml","form_type":"4"}},{"id":2831879,"issuer":{"id":112267,"kind":"organization","name":"SQZ Biotechnologies Co","symbol":"SQZ"},"owners":[{"id":54830,"kind":"person","name":"Sharei Armon","position":1,"cik":"0001829463","reported_name":"Sharei Armon","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-25T17:48:07.000Z","date":"2021-02-23","kind":"grant","acquired":true,"shares":195000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable as to 25% of the underlying securities on February 23, 2022 and in 36 substantially equal monthly installments thereafter."}],"balance_after":195000,"derivative":{"exercise_price":16.85,"expiration_date":"2031-02-22","underlying":"Common Stock","underlying_shares":195000},"source":{"system":"sec-edgar","filing":"0000899243-21-008254","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604477/000089924321008254/doc4.xml","form_type":"4"}},{"id":2909074,"issuer":{"id":112267,"kind":"organization","name":"SQZ Biotechnologies Co","symbol":"SQZ"},"owners":[{"id":54830,"kind":"person","name":"Sharei Armon","position":1,"cik":"0001829463","reported_name":"Sharei Armon","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-12T16:30:07.000Z","date":"2021-01-08","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Options were exercised and held for tax planning purposes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was originally granted for 286,514 shares. The option vested and and became exercisable as to the original share amount as to 25% of the underlying securities on October 11, 2017 and in 36 equal monthly installments thereafter."}],"balance_after":203986,"derivative":{"exercise_price":1.81,"expiration_date":"2026-10-10","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0000899243-21-001490","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1604477/000089924321001490/doc4.xml","form_type":"4"}},{"id":2909073,"issuer":{"id":112267,"kind":"organization","name":"SQZ Biotechnologies Co","symbol":"SQZ"},"owners":[{"id":54830,"kind":"person","name":"Sharei Armon","position":1,"cik":"0001829463","reported_name":"Sharei Armon","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-01-12T16:30:07.000Z","date":"2021-01-08","kind":"exercise","acquired":true,"shares":2500,"price":1.81,"value":4525.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Options were exercised and held for tax planning purposes."}],"balance_after":251713,"source":{"system":"sec-edgar","filing":"0000899243-21-001490","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604477/000089924321001490/doc4.xml","form_type":"4"}},{"id":2997163,"issuer":{"id":112267,"kind":"organization","name":"SQZ Biotechnologies Co","symbol":"SQZ"},"owners":[{"id":54830,"kind":"person","name":"Sharei Armon","position":1,"cik":"0001829463","reported_name":"Sharei Armon","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option","published_at":"2020-10-30T18:30:10.000Z","date":"2020-10-29","kind":"grant","acquired":true,"shares":105300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable as to 25% of the underlying shares on October 29, 2021 and in 36 equal monthly installments thereafter."}],"balance_after":105300,"derivative":{"exercise_price":16,"expiration_date":"2030-10-28","underlying":"Common Stock","underlying_shares":105300},"source":{"system":"sec-edgar","filing":"0000899243-20-029973","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604477/000089924320029973/doc4.xml","form_type":"4"}}]}